Reports
Reports
Sale
The global angiography catheter market size was valued at USD 1.51 billion in 2023, driven by the rising number of technological development activities across the globe. The market size is anticipated to grow at a CAGR of 7.6% during the forecast period of 2024-2032 to achieve a value of USD 2.91 billion by 2032.
An angiography catheter uses a catheter, x-ray imaging guidance, and an injection of contrast material to examine blood vessels in major areas of the body for abnormalities such as aneurysms, and diseases such as atherosclerosis (plaque). With the use of a catheter, it is possible to combine diagnosis and treatment in one procedure. Catheter angiography produces detailed, specific, and accurate pictures of the blood vessels and helps determine treatment options.
In catheter angiography, a thin plastic tube, called a catheter, is inserted into a blood vessel through a small incision in the skin. Once the catheter is guided to the area being observed, the technologist injects a contrast material through the catheter and captures images using a small dose of ionizing radiation (x-rays). This procedure is used to identify abnormalities, such as aneurysms in the aorta, in both, chest and abdomen, or in other arteries. It is also used to detect atherosclerotic (plaque) disease in the carotid artery of the neck, which can potentially result in blockage of blood flow to the brain and cause a stroke. Additionally, Itit is also used to identify an arteriovenous malformation in the body, among various other uses.
The growth of the global market is majorly driven by the increasing geriatric population across the globe. Along with the geriatric population, the increasing prevalence of cardiovascular diseases is also driving the market growth. The increasing adoption of a sedentary lifestyle among people, especially young adults, is a major factor driving the growth of the market. It is estimated that nearly 4 in every 5 CVD deaths occur in low- and middle-income countries. The increasing cardiovascular health issues are concentrated in high-income countries, further a major trend influencing theaiding the global angiography catheter market growth.
The increasing initiatives by agencies like the Food and Drug Administration FDA to ensure the quality and efficacy of the new developments, set to come to the market are acceptable and follow the manufacturing guidelines. For example, the FDA has recently announced the issuance of the latest guidance document to be considered by the manufacturers about taking care of the guidelines while submitting their new innovations for approvals which will result in improved quality of catheters in the market. Such initiatives are expected to directly support the market growth. The increasing technological advancements are also set to drive the market growth. For example, there are 15 angiography catheter devices in several stages of development across the globe, according to GlobalData’s medical device pipeline database. Such developments are increasing aiding the market demand directly.
Market Breakup by Product
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
The growth of the market is majorly driven by the continuously increasing preference for minimally invasive surgeries across the globe. People are now becoming more aware of minimally invasive surgical procedures which as a result is increasing the demand in the market. The increasing number of pcath labs in the market due to the increasing research and development is also contributing to the market growth. The increasing incidence of cardiovascular diseases across the globe is also greatly contributing to the global angiography catheter market growth.
The increasing initiatives and investments by the key players to develop more flexible, feasible, and cost-effective equipment to reduce healthcare expenditures and improve the quality of patient outcomes is expected to further intensify the market growth duringfor the forecast period. The iIncreasing burden of coronary arterial disease and increasing approvals of new and innovative products in the market areis also expected to anticipateaid the market demand in the coming years.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Angiography Catheter Market Overview
3.1 Global Angiography Catheter Market Historical Value (2017-2023)
3.2 Global Angiography Catheter Market Forecast Value (2024-2032)
4 Global Angiography Catheter Market Landscape
4.1 Global Angiography Catheter Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Angiography Catheter Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Application
5 Global Angiography Catheter Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Angiography Catheter Market Segmentation
6.1 Global Angiography Catheter Market by Product
6.1.1 Market Overview
6.1.2 Conventional Catheters
6.1.3 Drug Eluting Balloon Catheters
6.1.4 Cutting Balloon Catheters
6.1.5 Scoring Balloon Catheters
6.2 Global Angiography Catheter Market by Application
6.2.1 Market Overview
6.2.2 Coronary
6.2.3 Endovascular
6.2.4 Neurology
6.2.5 Oncology
6.2.6 Others
6.3 Global Angiography Catheter Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Ambulatory Surgical Centers
6.3.4 Cardiac Centers
6.3.5 Specialty Clinics
6.3.6 Others
6.4 Global Angiography Catheter Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Angiography Catheter Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Angiography Catheter Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Angiography Catheter Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Angiography Catheter Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Angiography Catheter Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Medtronic
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Boston Scientific Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Terumo Medical Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Cardinal Health
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Abbott
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 B. Braun Melsungen AG
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 BIOTRONIK SE & Co KG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 ZOLL Medical Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Cordis Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 OSCOR, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Terumo Europe NV
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 iVascular
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Teleflex Incorporated
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Angiography Catheter Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 1.51 billion in 2023, driven by the increasing research and development.
The market is anticipated to grow at a CAGR of 7.6% during the forecast period of 2024-2032, and is likely to reach a market value of USD 2.91 billion by 2032.
The increasing prevalence of CVDs cardiovascular diseases across the globe and increasing preference for minimally invasive procedures are among the major factors driving the market growth.
The increasing and continuous technological development of new and innovative angiography catheters is a major trend influencing the market growth.
There are several types of angiography catheters in the market such as conventional catheters, drug-eluting balloon catheters, cutting balloon catheters, and scoring balloon catheters.
They find huge applications in coronary, endovascular, neurology, oncology, and others.
End users in the market include hospitals, ambulatory surgical centers, cardiac centers, and specialty clinics.
Key players involved in the market are Medtronic, Boston Scientific Corporation, Terumo Medical Corporation, Cardinal Health, Abbott, B. Braun Melsungen AG, BIOTRONIK SE & Co KG, ZOLL Medical Corporation, Cordis Corporation, OSCOR, Inc., Terumo Europe NV, iVascular, and Teleflex Incorporated.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.